IB
Infant Bacerial Therapeutics AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Maria Ekdahl, was filed 23 May 2023.
Infant Bacerial Therapeutics AB: what insiders have been doing
Insider filings for Infant Bacerial Therapeutics AB are scarce in the Finansinspektionen feed, the latest one published on 23 May 2023. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€7,224
1 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 23 May 2023
Declarations1 total
- 25,000 shares@ SEK 3.29100.0% of flowTeckningsoptionFI:csv-46d5e61066f4006294b0Canonical exit: 18 Aug 2023 (T+90)
1 of 1 declaration
About Infant Bacerial Therapeutics AB
Infant Bacerial Therapeutics AB is a company focused on developing bacterial therapies for infants. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations